International Biotechnology Trust’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-57,000
Closed -$475K 66
2023
Q1
$475K Hold
57,000
0.13% 59
2022
Q4
$654K Hold
57,000
0.2% 57
2022
Q3
$718K Buy
57,000
+56,398
+9,368% +$710K 0.23% 56
2022
Q2
$57K Sell
602
-56,398
-99% -$5.34M 0.59% 39
2022
Q1
$19.3M Buy
+57,000
New +$19.3M 4.35% 6